Emmanuelle Clappier

24PUBLICATIONS
172CO-AUTHORS
Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Psychology of ageingRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Jun 17, 2026
<i>CEBP</i> and <i>ZEB2</i> alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

|Jun 08, 2026
Persistent <i>BCR::ABL1</i>-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL.

|May 13, 2026
Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Mar 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in <i>FANCM</i>-Associated Fanconi Anemia.

Francesco Pegoraro, Lise Larcher, Rathana Kim

Pageof 4

Frequent Collaborators

15 joint publications

Rathana Kim

10 joint publications

Nicolas Boissel

9 joint publications

Marie Passet

8 joint publications

Lionel Ades